Algo version: 0.98b
Ind-Swift Laboratories is listed at the NSE Exchange
Ind-Swift Laboratories [INDSWFTLAB.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Ind-Swift Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Ind-Swift Laboratories pays dividends. Last time was Wednesday 26th of October 2011 where the investors holding the stock on Tuesday 20th of September 2011 were paid INR1 per share. Over the last 8 times between 2004 and 2011, Ind-Swift Laboratories has paid INR9 with an average of INR1.13 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Ind-Swift Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR45.00, you would have made a profit of INR100.43 per share or 223.18%

Yes, the average daily trading liquidity for Ind-Swift Laboratories is INR1.03 million. You should therefore be able to get in and out of your positions relatively fast.

Ind-Swift Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 4.89, the company's ability to pay off the debt is good. Ind-Swift Laboratories has a very good net profit margin of 23.98% and should have very high tolerances against inflation.

We have calculated the inflation risk for Ind-Swift Laboratories to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.